Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peanut Hypersensitivity | 46 | 2023 | 211 | 13.270 |
Why?
|
Food Hypersensitivity | 53 | 2024 | 692 | 12.010 |
Why?
|
Allergens | 77 | 2024 | 1395 | 8.300 |
Why?
|
Desensitization, Immunologic | 46 | 2023 | 531 | 8.120 |
Why?
|
Hypersensitivity | 32 | 2024 | 1153 | 7.560 |
Why?
|
Climate Change | 13 | 2024 | 486 | 4.530 |
Why?
|
Immunoglobulin E | 53 | 2024 | 1500 | 4.300 |
Why?
|
Asthma | 41 | 2024 | 6154 | 3.400 |
Why?
|
Air Pollution | 14 | 2024 | 2303 | 3.130 |
Why?
|
Dermatitis, Atopic | 14 | 2024 | 708 | 2.620 |
Why?
|
T-Lymphocytes, Regulatory | 25 | 2022 | 3035 | 2.590 |
Why?
|
Anti-Allergic Agents | 12 | 2017 | 148 | 2.520 |
Why?
|
Basophils | 16 | 2024 | 407 | 2.400 |
Why?
|
Antigens, Plant | 18 | 2023 | 105 | 2.320 |
Why?
|
Immune Tolerance | 21 | 2024 | 2222 | 2.170 |
Why?
|
Antibodies, Anti-Idiotypic | 10 | 2018 | 354 | 2.140 |
Why?
|
Plant Proteins | 12 | 2022 | 367 | 1.970 |
Why?
|
Nut Hypersensitivity | 7 | 2023 | 32 | 1.960 |
Why?
|
Air Pollutants | 10 | 2024 | 2823 | 1.910 |
Why?
|
Immunotherapy | 19 | 2023 | 4610 | 1.820 |
Why?
|
Administration, Oral | 28 | 2023 | 4019 | 1.750 |
Why?
|
Food | 13 | 2024 | 776 | 1.740 |
Why?
|
Emollients | 4 | 2023 | 40 | 1.690 |
Why?
|
Cytokines | 36 | 2024 | 7261 | 1.680 |
Why?
|
Anaphylaxis | 9 | 2023 | 749 | 1.630 |
Why?
|
Epigenesis, Genetic | 10 | 2021 | 3717 | 1.450 |
Why?
|
Eosinophilic Esophagitis | 5 | 2023 | 192 | 1.370 |
Why?
|
Particulate Matter | 9 | 2024 | 2539 | 1.330 |
Why?
|
Th2 Cells | 9 | 2021 | 1017 | 1.330 |
Why?
|
Rhinitis, Allergic, Seasonal | 3 | 2020 | 104 | 1.170 |
Why?
|
T-Lymphocyte Subsets | 10 | 2023 | 1791 | 1.140 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2020 | 4279 | 1.130 |
Why?
|
Egg Hypersensitivity | 2 | 2019 | 47 | 1.110 |
Why?
|
STAT5 Transcription Factor | 4 | 2022 | 258 | 1.100 |
Why?
|
Humans | 279 | 2024 | 756111 | 1.100 |
Why?
|
Environmental Exposure | 11 | 2024 | 4357 | 1.080 |
Why?
|
Interleukin-10 | 6 | 2023 | 1163 | 1.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2021 | 971 | 1.040 |
Why?
|
Th1 Cells | 6 | 2021 | 999 | 1.020 |
Why?
|
Allergy and Immunology | 2 | 2019 | 173 | 1.020 |
Why?
|
Forkhead Transcription Factors | 8 | 2021 | 1595 | 1.000 |
Why?
|
DNA Methylation | 8 | 2021 | 4323 | 0.990 |
Why?
|
Immunoglobulin G | 18 | 2024 | 4526 | 0.950 |
Why?
|
Environmental Pollution | 2 | 2022 | 120 | 0.950 |
Why?
|
Ozone | 3 | 2023 | 467 | 0.940 |
Why?
|
Pollen | 2 | 2021 | 82 | 0.910 |
Why?
|
CpG Islands | 4 | 2021 | 1208 | 0.860 |
Why?
|
Photosynthesis | 1 | 2023 | 69 | 0.850 |
Why?
|
Nitrogen Dioxide | 3 | 2024 | 500 | 0.850 |
Why?
|
Greenhouse Effect | 1 | 2022 | 31 | 0.840 |
Why?
|
Motor Vehicles | 2 | 2024 | 281 | 0.840 |
Why?
|
Arsenic | 2 | 2017 | 342 | 0.840 |
Why?
|
Climate | 2 | 2023 | 147 | 0.840 |
Why?
|
Respiratory Mucosa | 2 | 2020 | 441 | 0.840 |
Why?
|
Eosinophils | 4 | 2022 | 945 | 0.830 |
Why?
|
Complement Activation | 1 | 2024 | 444 | 0.820 |
Why?
|
Antibodies, Viral | 13 | 2023 | 3126 | 0.810 |
Why?
|
Antibodies, Monoclonal | 9 | 2023 | 9113 | 0.810 |
Why?
|
Heat-Shock Response | 1 | 2023 | 179 | 0.800 |
Why?
|
B-Lymphocytes | 13 | 2024 | 4707 | 0.790 |
Why?
|
Premature Birth | 2 | 2024 | 1748 | 0.780 |
Why?
|
Dendritic Cells | 8 | 2021 | 2716 | 0.780 |
Why?
|
Child | 70 | 2024 | 79418 | 0.780 |
Why?
|
Autoimmune Diseases | 6 | 2023 | 2227 | 0.780 |
Why?
|
Immunity, Innate | 9 | 2024 | 3036 | 0.770 |
Why?
|
Excipients | 1 | 2021 | 97 | 0.760 |
Why?
|
Vehicle Emissions | 2 | 2024 | 651 | 0.760 |
Why?
|
2S Albumins, Plant | 7 | 2023 | 37 | 0.760 |
Why?
|
Computational Biology | 5 | 2024 | 3486 | 0.750 |
Why?
|
Supreme Court Decisions | 1 | 2022 | 132 | 0.750 |
Why?
|
United Nations | 1 | 2021 | 152 | 0.730 |
Why?
|
Epigenomics | 2 | 2020 | 928 | 0.730 |
Why?
|
Federal Government | 1 | 2022 | 260 | 0.700 |
Why?
|
HLA-A2 Antigen | 1 | 2020 | 212 | 0.690 |
Why?
|
Laboratories | 1 | 2023 | 460 | 0.680 |
Why?
|
Adolescent | 64 | 2023 | 87297 | 0.670 |
Why?
|
Public Health | 3 | 2023 | 2658 | 0.670 |
Why?
|
Child, Preschool | 42 | 2023 | 41848 | 0.660 |
Why?
|
CD8-Positive T-Lymphocytes | 8 | 2023 | 4516 | 0.650 |
Why?
|
Milk | 3 | 2019 | 443 | 0.650 |
Why?
|
Immunophenotyping | 6 | 2021 | 1865 | 0.650 |
Why?
|
Enterocolitis | 1 | 2020 | 106 | 0.650 |
Why?
|
Cross Reactions | 5 | 2021 | 814 | 0.640 |
Why?
|
Vaccines | 3 | 2023 | 833 | 0.640 |
Why?
|
Global Warming | 3 | 2024 | 77 | 0.630 |
Why?
|
Fungi | 1 | 2021 | 333 | 0.620 |
Why?
|
Asthma, Exercise-Induced | 1 | 2018 | 23 | 0.620 |
Why?
|
Carbon Monoxide | 2 | 2021 | 543 | 0.620 |
Why?
|
Lymphocytes | 3 | 2024 | 2598 | 0.620 |
Why?
|
Inhalation Exposure | 1 | 2021 | 429 | 0.610 |
Why?
|
Egg Proteins, Dietary | 1 | 2017 | 6 | 0.610 |
Why?
|
Infant | 32 | 2023 | 35828 | 0.590 |
Why?
|
Immunologic Factors | 7 | 2023 | 1580 | 0.590 |
Why?
|
Eczema | 1 | 2020 | 244 | 0.580 |
Why?
|
Skin | 6 | 2024 | 4443 | 0.570 |
Why?
|
Environment | 1 | 2023 | 1116 | 0.570 |
Why?
|
Immune System | 3 | 2023 | 794 | 0.570 |
Why?
|
Female | 107 | 2024 | 388229 | 0.560 |
Why?
|
Double-Blind Method | 19 | 2022 | 12353 | 0.560 |
Why?
|
T-Lymphocytes | 13 | 2022 | 10059 | 0.550 |
Why?
|
Skin Tests | 7 | 2020 | 637 | 0.550 |
Why?
|
Male | 115 | 2024 | 356852 | 0.540 |
Why?
|
Cadmium | 1 | 2017 | 214 | 0.530 |
Why?
|
Immunity | 2 | 2021 | 993 | 0.520 |
Why?
|
Biological Therapy | 1 | 2017 | 138 | 0.520 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 1180 | 0.520 |
Why?
|
Anacardium | 3 | 2023 | 6 | 0.520 |
Why?
|
Lymphocyte Activation | 9 | 2017 | 5418 | 0.510 |
Why?
|
Schools | 1 | 2024 | 1464 | 0.500 |
Why?
|
California | 6 | 2021 | 1401 | 0.500 |
Why?
|
Fetal Blood | 4 | 2021 | 1330 | 0.500 |
Why?
|
Environmental Pollutants | 2 | 2024 | 1241 | 0.500 |
Why?
|
Mutation, Missense | 2 | 2024 | 2554 | 0.490 |
Why?
|
Epinephrine | 3 | 2023 | 789 | 0.490 |
Why?
|
Antigen-Presenting Cells | 2 | 2021 | 944 | 0.480 |
Why?
|
Adult | 69 | 2024 | 218302 | 0.480 |
Why?
|
Twins, Monozygotic | 2 | 2014 | 465 | 0.470 |
Why?
|
Animals | 77 | 2024 | 167069 | 0.470 |
Why?
|
Phleum | 2 | 2020 | 5 | 0.470 |
Why?
|
Air Pollution, Indoor | 2 | 2024 | 885 | 0.470 |
Why?
|
Young Adult | 42 | 2022 | 58143 | 0.450 |
Why?
|
Sympathomimetics | 1 | 2013 | 56 | 0.450 |
Why?
|
Milk Hypersensitivity | 2 | 2012 | 78 | 0.440 |
Why?
|
Biological Products | 3 | 2023 | 908 | 0.440 |
Why?
|
Tumor Suppressor Proteins | 2 | 2014 | 2801 | 0.430 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3154 | 0.430 |
Why?
|
Lectins, C-Type | 3 | 2023 | 586 | 0.420 |
Why?
|
Common Variable Immunodeficiency | 2 | 2015 | 101 | 0.420 |
Why?
|
Mites | 1 | 2012 | 46 | 0.420 |
Why?
|
Monocytes | 6 | 2023 | 2560 | 0.410 |
Why?
|
Basophil Degranulation Test | 3 | 2023 | 19 | 0.410 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 2 | 2009 | 50 | 0.410 |
Why?
|
Ribosomal Protein S6 | 1 | 2012 | 71 | 0.400 |
Why?
|
Seed Storage Proteins | 4 | 2021 | 15 | 0.400 |
Why?
|
Maternal Exposure | 3 | 2021 | 1029 | 0.390 |
Why?
|
Rhinitis | 3 | 2022 | 746 | 0.390 |
Why?
|
Pyrophosphatases | 2 | 2016 | 139 | 0.380 |
Why?
|
Immunologic Memory | 5 | 2021 | 1331 | 0.380 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2012 | 112 | 0.380 |
Why?
|
Severity of Illness Index | 12 | 2022 | 15773 | 0.370 |
Why?
|
Immunity, Cellular | 2 | 2015 | 1543 | 0.370 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 2016 | 201 | 0.370 |
Why?
|
Brassica | 1 | 2020 | 39 | 0.370 |
Why?
|
Paraffin | 2 | 2020 | 37 | 0.360 |
Why?
|
Delivery of Health Care | 4 | 2023 | 5296 | 0.360 |
Why?
|
Detergents | 2 | 2022 | 234 | 0.360 |
Why?
|
Intestinal Mucosa | 2 | 2022 | 3003 | 0.350 |
Why?
|
Fermentation | 1 | 2020 | 146 | 0.350 |
Why?
|
Autoantibodies | 6 | 2023 | 2093 | 0.350 |
Why?
|
Dust | 1 | 2012 | 481 | 0.330 |
Why?
|
Research | 2 | 2015 | 1968 | 0.330 |
Why?
|
Chemokines, C | 1 | 2008 | 10 | 0.320 |
Why?
|
Nasal Polyps | 2 | 2014 | 396 | 0.320 |
Why?
|
Middle Aged | 48 | 2024 | 218357 | 0.320 |
Why?
|
Universities | 1 | 2014 | 976 | 0.320 |
Why?
|
Receptors, Immunologic | 4 | 2023 | 1427 | 0.310 |
Why?
|
Epithelial Cells | 4 | 2023 | 3668 | 0.310 |
Why?
|
Cells, Cultured | 12 | 2020 | 18929 | 0.310 |
Why?
|
Mast Cells | 4 | 2020 | 1435 | 0.310 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 214 | 0.300 |
Why?
|
Probiotics | 3 | 2024 | 372 | 0.300 |
Why?
|
Flow Cytometry | 11 | 2023 | 5841 | 0.300 |
Why?
|
Graft Rejection | 11 | 2000 | 4233 | 0.300 |
Why?
|
Proteomics | 7 | 2023 | 3761 | 0.300 |
Why?
|
Infant, Newborn | 10 | 2024 | 26034 | 0.300 |
Why?
|
Hot Temperature | 4 | 2024 | 1432 | 0.290 |
Why?
|
Polyendocrinopathies, Autoimmune | 1 | 2008 | 55 | 0.290 |
Why?
|
Hypersensitivity, Immediate | 2 | 2022 | 343 | 0.290 |
Why?
|
Epithelium | 3 | 2023 | 1609 | 0.290 |
Why?
|
Schools, Medical | 1 | 2014 | 877 | 0.290 |
Why?
|
Receptors, IgE | 2 | 2021 | 381 | 0.290 |
Why?
|
Gene Expression Profiling | 7 | 2024 | 9341 | 0.280 |
Why?
|
Receptors, IgG | 2 | 2020 | 569 | 0.280 |
Why?
|
STAT Transcription Factors | 1 | 2007 | 188 | 0.280 |
Why?
|
Esophagus | 1 | 2013 | 1026 | 0.280 |
Why?
|
Gene Expression | 8 | 2021 | 7582 | 0.280 |
Why?
|
Phenotype | 10 | 2024 | 16442 | 0.280 |
Why?
|
Cell Adhesion Molecules | 5 | 2021 | 1600 | 0.280 |
Why?
|
Interferon-gamma | 8 | 2021 | 3123 | 0.280 |
Why?
|
Tobacco Smoke Pollution | 1 | 2012 | 811 | 0.280 |
Why?
|
Vaccination | 6 | 2024 | 3339 | 0.270 |
Why?
|
Epitope Mapping | 3 | 2022 | 297 | 0.270 |
Why?
|
Pilot Projects | 9 | 2022 | 8498 | 0.270 |
Why?
|
Heat-Shock Proteins | 4 | 1994 | 797 | 0.270 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 3 | 2018 | 112 | 0.260 |
Why?
|
Vegetables | 2 | 2020 | 1195 | 0.260 |
Why?
|
Bronchi | 3 | 2018 | 845 | 0.260 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2012 | 1757 | 0.260 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2015 | 553 | 0.260 |
Why?
|
Seeds | 3 | 2020 | 114 | 0.250 |
Why?
|
Quality of Life | 8 | 2023 | 13215 | 0.250 |
Why?
|
Gastrointestinal Tract | 3 | 2022 | 830 | 0.250 |
Why?
|
Pregnancy | 11 | 2024 | 29548 | 0.250 |
Why?
|
Blood Pressure | 1 | 2021 | 8500 | 0.250 |
Why?
|
Sinusitis | 2 | 2014 | 989 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3134 | 0.240 |
Why?
|
Adrenal Cortex Hormones | 3 | 2009 | 1867 | 0.240 |
Why?
|
United States | 15 | 2024 | 71909 | 0.240 |
Why?
|
Treatment Outcome | 19 | 2023 | 64582 | 0.240 |
Why?
|
Parents | 1 | 2018 | 3532 | 0.240 |
Why?
|
Propane | 1 | 2024 | 12 | 0.240 |
Why?
|
Benzo(a)pyrene | 1 | 2024 | 25 | 0.240 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2057 | 0.240 |
Why?
|
Chemokines | 1 | 2009 | 958 | 0.240 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2008 | 1338 | 0.240 |
Why?
|
Glycoproteins | 5 | 2023 | 2200 | 0.240 |
Why?
|
Juglans | 2 | 2017 | 45 | 0.230 |
Why?
|
Kidney Transplantation | 11 | 2000 | 4148 | 0.230 |
Why?
|
Rhinovirus | 3 | 2021 | 202 | 0.230 |
Why?
|
Milk Proteins | 2 | 2017 | 163 | 0.230 |
Why?
|
Administration, Sublingual | 2 | 2014 | 61 | 0.230 |
Why?
|
Electricity | 1 | 2024 | 182 | 0.220 |
Why?
|
Amino Acid Substitution | 1 | 2008 | 1736 | 0.220 |
Why?
|
Antigens, Surface | 1 | 2007 | 1608 | 0.220 |
Why?
|
Neutropenia | 1 | 2008 | 883 | 0.220 |
Why?
|
Antibodies, Neutralizing | 6 | 2022 | 1919 | 0.220 |
Why?
|
West Virginia | 1 | 2022 | 31 | 0.220 |
Why?
|
Anti-Asthmatic Agents | 4 | 2015 | 559 | 0.210 |
Why?
|
Receptors, Interleukin-2 | 4 | 2022 | 551 | 0.210 |
Why?
|
Leukotriene B4 | 1 | 2024 | 281 | 0.210 |
Why?
|
Reference Standards | 3 | 2018 | 1004 | 0.210 |
Why?
|
Rats, Inbred Lew | 18 | 2024 | 1068 | 0.210 |
Why?
|
Monkeypox virus | 1 | 2023 | 41 | 0.210 |
Why?
|
Cattle | 4 | 2019 | 3845 | 0.210 |
Why?
|
Adaptive Immunity | 3 | 2024 | 721 | 0.210 |
Why?
|
Aged | 26 | 2024 | 167585 | 0.210 |
Why?
|
Mass Spectrometry | 2 | 2020 | 2182 | 0.210 |
Why?
|
Inflammation | 8 | 2024 | 10716 | 0.210 |
Why?
|
Tetanus | 1 | 2022 | 51 | 0.210 |
Why?
|
Placenta | 3 | 2023 | 1693 | 0.200 |
Why?
|
Avidin | 2 | 2023 | 43 | 0.200 |
Why?
|
Immunologic Tests | 2 | 2020 | 103 | 0.200 |
Why?
|
Interleukin-4 | 4 | 2021 | 1113 | 0.200 |
Why?
|
Twins | 2 | 2021 | 338 | 0.200 |
Why?
|
United States Environmental Protection Agency | 1 | 2022 | 139 | 0.200 |
Why?
|
Permeability | 2 | 2023 | 718 | 0.200 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1668 | 0.200 |
Why?
|
Body Fluids | 1 | 2024 | 319 | 0.200 |
Why?
|
Th17 Cells | 3 | 2021 | 779 | 0.200 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2471 | 0.200 |
Why?
|
Power Plants | 1 | 2022 | 124 | 0.200 |
Why?
|
Adenosine Triphosphatases | 4 | 1994 | 833 | 0.200 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2022 | 89 | 0.200 |
Why?
|
Enteritis | 1 | 2023 | 162 | 0.200 |
Why?
|
Single-Cell Analysis | 5 | 2024 | 2325 | 0.190 |
Why?
|
Nuts | 2 | 2020 | 262 | 0.190 |
Why?
|
NADH, NADPH Oxidoreductases | 2 | 1992 | 93 | 0.190 |
Why?
|
Epitopes | 3 | 2023 | 2502 | 0.190 |
Why?
|
Convalescence | 1 | 2021 | 106 | 0.190 |
Why?
|
Severe Combined Immunodeficiency | 2 | 2015 | 224 | 0.190 |
Why?
|
Spores, Fungal | 1 | 2021 | 90 | 0.190 |
Why?
|
Autoantigens | 4 | 2023 | 870 | 0.190 |
Why?
|
Placebos | 3 | 2021 | 1667 | 0.190 |
Why?
|
Forced Expiratory Volume | 3 | 2018 | 1797 | 0.190 |
Why?
|
Pistacia | 1 | 2020 | 7 | 0.180 |
Why?
|
Petrolatum | 1 | 2020 | 7 | 0.180 |
Why?
|
Diet | 4 | 2023 | 7965 | 0.180 |
Why?
|
Education, Medical | 2 | 2023 | 1721 | 0.180 |
Why?
|
Cells | 1 | 2021 | 164 | 0.180 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2020 | 90 | 0.180 |
Why?
|
Mass Vaccination | 1 | 2021 | 109 | 0.180 |
Why?
|
Tight Junctions | 2 | 2022 | 314 | 0.180 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18009 | 0.180 |
Why?
|
Antioxidants | 2 | 2023 | 1653 | 0.180 |
Why?
|
Phosphorylation | 6 | 2012 | 8312 | 0.180 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 2 | 2010 | 57 | 0.170 |
Why?
|
Chemokine CCL1 | 2 | 2010 | 20 | 0.170 |
Why?
|
Picornaviridae Infections | 1 | 2021 | 94 | 0.170 |
Why?
|
Cats | 1 | 2021 | 969 | 0.170 |
Why?
|
Cell Degranulation | 1 | 2020 | 280 | 0.170 |
Why?
|
Immunoconjugates | 5 | 1998 | 870 | 0.170 |
Why?
|
Triticum | 2 | 2018 | 88 | 0.170 |
Why?
|
Cardiovascular Diseases | 3 | 2020 | 15659 | 0.170 |
Why?
|
Cyclosporine | 5 | 1998 | 753 | 0.170 |
Why?
|
Cell Movement | 2 | 2010 | 5178 | 0.170 |
Why?
|
Antigens, CD | 8 | 2018 | 3909 | 0.170 |
Why?
|
World Health Organization | 2 | 2023 | 1309 | 0.160 |
Why?
|
Wheat Hypersensitivity | 1 | 2018 | 11 | 0.160 |
Why?
|
Germinal Center | 1 | 2022 | 379 | 0.160 |
Why?
|
CD40 Ligand | 1 | 2000 | 489 | 0.160 |
Why?
|
Immunoglobulin A | 2 | 2020 | 971 | 0.160 |
Why?
|
Coronavirus | 1 | 2021 | 151 | 0.160 |
Why?
|
Mercury | 1 | 2021 | 290 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2024 | 695 | 0.160 |
Why?
|
Mice | 19 | 2023 | 80709 | 0.160 |
Why?
|
Environmental Policy | 1 | 2018 | 35 | 0.150 |
Why?
|
Agglutination | 1 | 2017 | 41 | 0.150 |
Why?
|
Factor VIII | 1 | 2000 | 349 | 0.150 |
Why?
|
Diet, Reducing | 1 | 2021 | 486 | 0.150 |
Why?
|
Vital Capacity | 2 | 2018 | 959 | 0.150 |
Why?
|
Antibody Affinity | 1 | 2018 | 245 | 0.150 |
Why?
|
Immunosuppressive Agents | 7 | 2014 | 4093 | 0.150 |
Why?
|
Feces | 2 | 2022 | 1450 | 0.150 |
Why?
|
Perforin | 2 | 2008 | 167 | 0.150 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2021 | 485 | 0.150 |
Why?
|
Comorbidity | 4 | 2022 | 10534 | 0.150 |
Why?
|
Clinical Trials as Topic | 4 | 2022 | 8014 | 0.150 |
Why?
|
Expert Testimony | 1 | 2020 | 362 | 0.150 |
Why?
|
Receptors, Interleukin-13 | 1 | 2017 | 13 | 0.150 |
Why?
|
Receptors, Interleukin-5 | 1 | 2017 | 20 | 0.150 |
Why?
|
Eosinophilia | 2 | 2021 | 557 | 0.150 |
Why?
|
Chemokine CCL5 | 4 | 1997 | 214 | 0.150 |
Why?
|
Research Support as Topic | 1 | 2022 | 700 | 0.150 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2021 | 822 | 0.140 |
Why?
|
Monitoring, Immunologic | 1 | 2017 | 95 | 0.140 |
Why?
|
Egg Proteins | 1 | 2017 | 57 | 0.140 |
Why?
|
Feedback | 1 | 2021 | 786 | 0.140 |
Why?
|
B-Lymphocyte Subsets | 1 | 2018 | 242 | 0.140 |
Why?
|
Academies and Institutes | 1 | 2019 | 317 | 0.140 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2017 | 57 | 0.140 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2021 | 649 | 0.140 |
Why?
|
Reperfusion Injury | 7 | 1997 | 1014 | 0.140 |
Why?
|
Disasters | 1 | 2023 | 512 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 17684 | 0.140 |
Why?
|
Up-Regulation | 6 | 2022 | 4116 | 0.140 |
Why?
|
Drug Eruptions | 1 | 2020 | 332 | 0.140 |
Why?
|
Carya | 1 | 2016 | 2 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 597 | 0.140 |
Why?
|
Health Facilities | 1 | 2022 | 574 | 0.140 |
Why?
|
Trypanosoma cruzi | 3 | 1994 | 199 | 0.140 |
Why?
|
Chemotaxis | 2 | 2010 | 595 | 0.140 |
Why?
|
Adolescent Development | 1 | 2020 | 281 | 0.140 |
Why?
|
Prevalence | 5 | 2021 | 15599 | 0.140 |
Why?
|
Neutrophils | 3 | 2022 | 3736 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2019 | 864 | 0.140 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2181 | 0.140 |
Why?
|
Crithidia fasciculata | 2 | 1993 | 2 | 0.130 |
Why?
|
Molecular Mimicry | 1 | 2017 | 200 | 0.130 |
Why?
|
Risk Factors | 7 | 2021 | 73898 | 0.130 |
Why?
|
Gliadin | 1 | 2016 | 80 | 0.130 |
Why?
|
Policy Making | 1 | 2019 | 540 | 0.130 |
Why?
|
Environmental Health | 1 | 2018 | 279 | 0.130 |
Why?
|
Pregnancy Outcome | 2 | 2023 | 2869 | 0.130 |
Why?
|
Gene Expression Regulation | 8 | 2018 | 11881 | 0.130 |
Why?
|
Thinking | 1 | 2019 | 316 | 0.130 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2788 | 0.130 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1722 | 0.130 |
Why?
|
Glycosylation | 2 | 2024 | 1089 | 0.130 |
Why?
|
RNA | 4 | 2023 | 2711 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2023 | 1393 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 25715 | 0.130 |
Why?
|
Vaccines, Synthetic | 3 | 2023 | 616 | 0.130 |
Why?
|
Growth Substances | 2 | 1997 | 764 | 0.130 |
Why?
|
Confidence Intervals | 1 | 2021 | 2936 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5180 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2018 | 330 | 0.130 |
Why?
|
Advisory Committees | 1 | 2019 | 788 | 0.130 |
Why?
|
Trypanosoma | 2 | 1992 | 16 | 0.130 |
Why?
|
Nails | 1 | 2017 | 294 | 0.120 |
Why?
|
Spermidine | 2 | 1992 | 61 | 0.120 |
Why?
|
Seasons | 1 | 2021 | 1515 | 0.120 |
Why?
|
Government Regulation | 1 | 2019 | 523 | 0.120 |
Why?
|
Introns | 1 | 2018 | 974 | 0.120 |
Why?
|
Signal Transduction | 5 | 2022 | 23254 | 0.120 |
Why?
|
Chemokine CCL2 | 3 | 1997 | 596 | 0.120 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2015 | 112 | 0.120 |
Why?
|
Kidney | 12 | 2000 | 6997 | 0.120 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2015 | 172 | 0.120 |
Why?
|
New Hampshire | 1 | 2014 | 173 | 0.120 |
Why?
|
HLA-DQ Antigens | 1 | 2015 | 208 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 1996 | 338 | 0.120 |
Why?
|
Immunoglobulin Variable Region | 2 | 2018 | 419 | 0.120 |
Why?
|
Antiprotozoal Agents | 2 | 1992 | 86 | 0.120 |
Why?
|
Bacterial Infections | 1 | 2022 | 1401 | 0.120 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2015 | 321 | 0.120 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2248 | 0.120 |
Why?
|
Emigration and Immigration | 1 | 1997 | 395 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2020 | 4342 | 0.110 |
Why?
|
Systems Biology | 1 | 2018 | 479 | 0.110 |
Why?
|
Polymerase Chain Reaction | 5 | 2017 | 6067 | 0.110 |
Why?
|
Twins, Dizygotic | 1 | 2014 | 236 | 0.110 |
Why?
|
Clone Cells | 2 | 2015 | 1652 | 0.110 |
Why?
|
Immunoglobulin M | 2 | 2024 | 1519 | 0.110 |
Why?
|
Antigens | 2 | 2023 | 1442 | 0.110 |
Why?
|
Diet, Sodium-Restricted | 1 | 2015 | 290 | 0.110 |
Why?
|
Water | 1 | 2020 | 1394 | 0.110 |
Why?
|
Consensus Sequence | 1 | 2014 | 366 | 0.110 |
Why?
|
Bacteria | 2 | 2022 | 2174 | 0.110 |
Why?
|
Amino Acid Isomerases | 1 | 1993 | 31 | 0.110 |
Why?
|
Glutathione | 3 | 1997 | 578 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1559 | 0.110 |
Why?
|
Glycosyltransferases | 1 | 2024 | 117 | 0.110 |
Why?
|
HLA-DR Antigens | 1 | 2015 | 629 | 0.110 |
Why?
|
Guanidines | 1 | 1994 | 191 | 0.110 |
Why?
|
Intestinal Atresia | 1 | 2013 | 69 | 0.110 |
Why?
|
Rats | 21 | 2024 | 23564 | 0.110 |
Why?
|
Diet, Fat-Restricted | 1 | 2015 | 328 | 0.110 |
Why?
|
Leukocyte Count | 3 | 2022 | 1590 | 0.110 |
Why?
|
Mutation | 13 | 2020 | 29764 | 0.110 |
Why?
|
Metabolome | 1 | 2019 | 969 | 0.110 |
Why?
|
Granuloma | 1 | 2015 | 325 | 0.110 |
Why?
|
Urban Population | 1 | 2021 | 2012 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2481 | 0.100 |
Why?
|
Chronic Disease | 4 | 2023 | 9202 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
Diphtheria Toxin | 1 | 2013 | 252 | 0.100 |
Why?
|
Curriculum | 2 | 2023 | 3676 | 0.100 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 175 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 435 | 0.100 |
Why?
|
Disease Progression | 5 | 2024 | 13432 | 0.100 |
Why?
|
Hepatitis | 1 | 2014 | 231 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2415 | 0.100 |
Why?
|
Transplantation, Homologous | 9 | 2000 | 4665 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1196 | 0.100 |
Why?
|
P-Selectin | 4 | 1998 | 601 | 0.100 |
Why?
|
Injections, Intramuscular | 1 | 2013 | 554 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15228 | 0.100 |
Why?
|
Case-Control Studies | 6 | 2021 | 21917 | 0.100 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2820 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1828 | 0.100 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1994 | 397 | 0.100 |
Why?
|
Dietary Fiber | 1 | 2015 | 758 | 0.100 |
Why?
|
Amino Acid Sequence | 7 | 2022 | 13425 | 0.100 |
Why?
|
Specimen Handling | 1 | 2016 | 706 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2760 | 0.100 |
Why?
|
bcl-X Protein | 1 | 2013 | 410 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 795 | 0.100 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2024 | 2140 | 0.100 |
Why?
|
Antibody Formation | 3 | 2022 | 1381 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 374 | 0.090 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2012 | 160 | 0.090 |
Why?
|
RNA, Messenger | 8 | 2022 | 12755 | 0.090 |
Why?
|
STAT6 Transcription Factor | 1 | 2011 | 186 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1370 | 0.090 |
Why?
|
Membrane Glycoproteins | 5 | 2023 | 3676 | 0.090 |
Why?
|
Lactobacillales | 1 | 2020 | 2 | 0.090 |
Why?
|
Methylation | 1 | 2014 | 1076 | 0.090 |
Why?
|
Interleukin-7 | 1 | 2011 | 140 | 0.090 |
Why?
|
Rats, Inbred F344 | 8 | 2000 | 806 | 0.090 |
Why?
|
Cell Communication | 3 | 2013 | 1634 | 0.090 |
Why?
|
Genomics | 3 | 2018 | 5742 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1186 | 0.090 |
Why?
|
Serum Amyloid A Protein | 1 | 2011 | 125 | 0.090 |
Why?
|
Dietary Proteins | 1 | 2016 | 938 | 0.090 |
Why?
|
Amino Acid Motifs | 3 | 2019 | 931 | 0.090 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2014 | 203 | 0.090 |
Why?
|
Base Sequence | 5 | 2014 | 12439 | 0.090 |
Why?
|
Interleukin-1 | 3 | 2012 | 1250 | 0.090 |
Why?
|
Cholangitis, Sclerosing | 1 | 2012 | 178 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2024 | 781 | 0.090 |
Why?
|
Heart Transplantation | 1 | 2024 | 3075 | 0.090 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5787 | 0.090 |
Why?
|
Ethmoid Sinus | 1 | 2010 | 58 | 0.090 |
Why?
|
Membrane Proteins | 4 | 2021 | 7825 | 0.090 |
Why?
|
Nuclear Proteins | 2 | 2015 | 5787 | 0.090 |
Why?
|
Clonal Anergy | 1 | 2011 | 169 | 0.090 |
Why?
|
High-Throughput Screening Assays | 2 | 2021 | 939 | 0.090 |
Why?
|
Genome, Human | 2 | 2014 | 4391 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 173 | 0.090 |
Why?
|
Drug Approval | 1 | 2017 | 814 | 0.090 |
Why?
|
Ecology | 1 | 2020 | 103 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2669 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 544 | 0.090 |
Why?
|
Carrier Proteins | 2 | 1994 | 4939 | 0.090 |
Why?
|
Skin Diseases | 1 | 2019 | 1090 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3297 | 0.090 |
Why?
|
STAT1 Transcription Factor | 1 | 2011 | 333 | 0.090 |
Why?
|
Interleukin-13 | 2 | 2023 | 372 | 0.090 |
Why?
|
Behavior Therapy | 1 | 2015 | 859 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2030 | 0.090 |
Why?
|
Cell Count | 2 | 2012 | 1834 | 0.080 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 467 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2022 | 11439 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2020 | 12482 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 2021 | 7574 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2016 | 674 | 0.080 |
Why?
|
Data Collection | 1 | 2019 | 3306 | 0.080 |
Why?
|
Prognosis | 3 | 2018 | 29463 | 0.080 |
Why?
|
Medical History Taking | 1 | 2013 | 774 | 0.080 |
Why?
|
Vancomycin | 1 | 2012 | 500 | 0.080 |
Why?
|
Vitamin D | 2 | 2021 | 3276 | 0.080 |
Why?
|
Interleukin-5 | 2 | 2021 | 266 | 0.080 |
Why?
|
Chemokines, CC | 1 | 2010 | 282 | 0.080 |
Why?
|
Receptors, CCR8 | 1 | 2009 | 28 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3603 | 0.080 |
Why?
|
Immune Sera | 2 | 2021 | 611 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1914 | 0.080 |
Why?
|
Pandemics | 4 | 2021 | 8570 | 0.080 |
Why?
|
Receptors, CCR4 | 1 | 2009 | 77 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2926 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
Antigens, Differentiation | 5 | 1998 | 847 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 976 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 999 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2014 | 783 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3343 | 0.080 |
Why?
|
Plant Extracts | 1 | 2012 | 494 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2706 | 0.080 |
Why?
|
Transcription Factors | 3 | 2015 | 12069 | 0.080 |
Why?
|
Child Development | 1 | 2020 | 2269 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58608 | 0.080 |
Why?
|
Drug Hypersensitivity | 1 | 2017 | 905 | 0.080 |
Why?
|
Molecular Sequence Data | 8 | 2018 | 17607 | 0.080 |
Why?
|
Child Abuse | 1 | 1997 | 1066 | 0.080 |
Why?
|
Lung Diseases | 1 | 2018 | 1906 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2923 | 0.080 |
Why?
|
HL-60 Cells | 1 | 2008 | 364 | 0.080 |
Why?
|
Steroids | 2 | 2023 | 923 | 0.070 |
Why?
|
Binding Sites | 2 | 2014 | 6038 | 0.070 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2008 | 132 | 0.070 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 375 | 0.070 |
Why?
|
Family | 2 | 2019 | 3188 | 0.070 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2007 | 84 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1755 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12160 | 0.070 |
Why?
|
Antigens, Viral | 2 | 2022 | 979 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2022 | 1001 | 0.070 |
Why?
|
Sequence Analysis, DNA | 3 | 2019 | 4703 | 0.070 |
Why?
|
Safety | 1 | 2012 | 1147 | 0.070 |
Why?
|
Antigen Presentation | 1 | 2013 | 1240 | 0.070 |
Why?
|
Administration, Cutaneous | 2 | 2021 | 712 | 0.070 |
Why?
|
Aging | 3 | 2022 | 8595 | 0.070 |
Why?
|
Chromosome Mapping | 2 | 2014 | 4627 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6481 | 0.070 |
Why?
|
Nasal Mucosa | 1 | 2010 | 413 | 0.070 |
Why?
|
South Africa | 2 | 2023 | 1794 | 0.070 |
Why?
|
Granzymes | 1 | 2008 | 274 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3376 | 0.070 |
Why?
|
Time Factors | 6 | 2020 | 39991 | 0.070 |
Why?
|
Codon, Nonsense | 1 | 2008 | 280 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 610 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2019 | 3506 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18372 | 0.070 |
Why?
|
Escherichia coli | 2 | 2022 | 4210 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 615 | 0.070 |
Why?
|
Graft Survival | 1 | 1996 | 3662 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2407 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1824 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10256 | 0.070 |
Why?
|
Risk Assessment | 2 | 2020 | 23956 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2004 | 0.070 |
Why?
|
Protozoan Proteins | 1 | 1992 | 834 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2666 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2013 | 817 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 1917 | 0.060 |
Why?
|
Kinetics | 4 | 2021 | 6371 | 0.060 |
Why?
|
Hospitalization | 4 | 2022 | 10683 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39187 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 2 | 1993 | 2698 | 0.060 |
Why?
|
Cell Separation | 1 | 2010 | 1718 | 0.060 |
Why?
|
Sequence Alignment | 2 | 2019 | 2174 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1534 | 0.060 |
Why?
|
Adiposity | 1 | 2014 | 1846 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2271 | 0.060 |
Why?
|
Intestines | 1 | 2013 | 1902 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2017 | 1747 | 0.060 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2562 | 0.060 |
Why?
|
Spleen | 3 | 2021 | 2275 | 0.060 |
Why?
|
Phosphate-Binding Proteins | 1 | 2024 | 86 | 0.060 |
Why?
|
RNA, Viral | 2 | 2022 | 2829 | 0.060 |
Why?
|
Neointima | 1 | 2024 | 133 | 0.060 |
Why?
|
Irritants | 1 | 2023 | 43 | 0.050 |
Why?
|
Biopsy | 2 | 2014 | 6760 | 0.050 |
Why?
|
Macadamia | 1 | 2022 | 1 | 0.050 |
Why?
|
Cytophotometry | 1 | 2022 | 8 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 1960 | 0.050 |
Why?
|
Genetic Loci | 1 | 2012 | 2610 | 0.050 |
Why?
|
Receptors, CCR7 | 1 | 2023 | 108 | 0.050 |
Why?
|
NF-kappa B | 2 | 2022 | 2481 | 0.050 |
Why?
|
Psoriasis | 1 | 2011 | 935 | 0.050 |
Why?
|
Immunodominant Epitopes | 1 | 2023 | 239 | 0.050 |
Why?
|
Mass Screening | 1 | 2018 | 5411 | 0.050 |
Why?
|
Apoptosis | 3 | 2018 | 9445 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 12847 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3346 | 0.050 |
Why?
|
Down-Regulation | 1 | 2009 | 2909 | 0.050 |
Why?
|
Receptors, KIR | 1 | 2022 | 113 | 0.050 |
Why?
|
Cooking | 1 | 2024 | 311 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2022 | 157 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2022 | 193 | 0.050 |
Why?
|
Mongolia | 1 | 2021 | 92 | 0.050 |
Why?
|
Cullin Proteins | 1 | 2022 | 178 | 0.050 |
Why?
|
Administration, Topical | 1 | 2023 | 697 | 0.050 |
Why?
|
Leishmania | 2 | 1992 | 63 | 0.050 |
Why?
|
Immunoglobulin D | 1 | 2021 | 57 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4569 | 0.050 |
Why?
|
Sesamum | 1 | 2020 | 20 | 0.050 |
Why?
|
Macrophages | 6 | 2019 | 5702 | 0.050 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 101 | 0.050 |
Why?
|
Homeostasis | 2 | 2022 | 3284 | 0.050 |
Why?
|
Immunogenetics | 1 | 2020 | 66 | 0.050 |
Why?
|
Diet Therapy | 1 | 2021 | 151 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2015 | 9561 | 0.050 |
Why?
|
Prospective Studies | 4 | 2022 | 54040 | 0.040 |
Why?
|
Infant Food | 1 | 2021 | 141 | 0.040 |
Why?
|
Peptide Library | 1 | 2021 | 347 | 0.040 |
Why?
|
Immunity, Mucosal | 1 | 2023 | 471 | 0.040 |
Why?
|
Genes, Immunoglobulin | 1 | 2021 | 287 | 0.040 |
Why?
|
Molecular Weight | 2 | 1993 | 2182 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 339 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2447 | 0.040 |
Why?
|
Toll-Like Receptors | 2 | 2015 | 591 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2021 | 343 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2020 | 238 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 79746 | 0.040 |
Why?
|
Ferrosoferric Oxide | 1 | 2021 | 348 | 0.040 |
Why?
|
Cough | 1 | 2023 | 595 | 0.040 |
Why?
|
Blood Donors | 1 | 2021 | 342 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 288 | 0.040 |
Why?
|
Housing | 1 | 2024 | 664 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2023 | 20002 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2019 | 90 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2023 | 914 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 678 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2021 | 613 | 0.040 |
Why?
|
RNA, Bacterial | 1 | 2021 | 383 | 0.040 |
Why?
|
Rats, Inbred Strains | 2 | 1998 | 2082 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2021 | 358 | 0.040 |
Why?
|
Receptors, Prostaglandin | 1 | 2018 | 54 | 0.040 |
Why?
|
Paris | 1 | 2018 | 50 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 516 | 0.040 |
Why?
|
Losartan | 1 | 2000 | 258 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14393 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7475 | 0.040 |
Why?
|
Pedigree | 2 | 2017 | 4565 | 0.040 |
Why?
|
Ebolavirus | 1 | 2021 | 253 | 0.040 |
Why?
|
Connective Tissue Diseases | 1 | 2021 | 285 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2023 | 1451 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6026 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12950 | 0.040 |
Why?
|
Interleukin-2 | 2 | 2022 | 1872 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2021 | 656 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 544 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2022 | 600 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 1698 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2009 | 1882 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2414 | 0.040 |
Why?
|
DNA, Protozoan | 3 | 1994 | 227 | 0.040 |
Why?
|
Host-Parasite Interactions | 1 | 2020 | 299 | 0.040 |
Why?
|
Proteinuria | 5 | 1997 | 585 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 412 | 0.040 |
Why?
|
Algorithms | 1 | 2018 | 13940 | 0.040 |
Why?
|
Mucins | 2 | 1997 | 568 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2014 | 11025 | 0.040 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2017 | 363 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2017 | 85 | 0.040 |
Why?
|
Interleukin-6 | 4 | 2020 | 3203 | 0.040 |
Why?
|
Cohort Studies | 3 | 2022 | 41121 | 0.040 |
Why?
|
Risk | 2 | 2021 | 9626 | 0.040 |
Why?
|
Chemical Precipitation | 1 | 2017 | 176 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 560 | 0.040 |
Why?
|
Hemophilia A | 1 | 2000 | 360 | 0.040 |
Why?
|
Peptides | 2 | 2022 | 4321 | 0.030 |
Why?
|
Isoantibodies | 1 | 2000 | 642 | 0.030 |
Why?
|
Microfluidics | 1 | 2022 | 655 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1897 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2017 | 161 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 608 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2017 | 348 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2019 | 411 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2017 | 911 | 0.030 |
Why?
|
Organ Preservation Solutions | 1 | 1997 | 100 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 2017 | 643 | 0.030 |
Why?
|
Drug Design | 2 | 1992 | 1064 | 0.030 |
Why?
|
Glutens | 1 | 2018 | 239 | 0.030 |
Why?
|
Blood Proteins | 1 | 2021 | 1153 | 0.030 |
Why?
|
Ciprofloxacin | 1 | 1998 | 311 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2018 | 352 | 0.030 |
Why?
|
Foster Home Care | 1 | 1997 | 132 | 0.030 |
Why?
|
Nephrons | 1 | 1997 | 158 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2019 | 1991 | 0.030 |
Why?
|
Edetic Acid | 1 | 2016 | 281 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1007 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5785 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 21780 | 0.030 |
Why?
|
Interleukin-3 | 1 | 2016 | 421 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14654 | 0.030 |
Why?
|
Prisons | 1 | 1997 | 169 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1811 | 0.030 |
Why?
|
Limit of Detection | 1 | 2016 | 279 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 1996 | 258 | 0.030 |
Why?
|
Brain Death | 1 | 1998 | 342 | 0.030 |
Why?
|
Myosin Type II | 1 | 2014 | 71 | 0.030 |
Why?
|
Macrophage Activation | 1 | 1997 | 547 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1198 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2000 | 1437 | 0.030 |
Why?
|
Furans | 1 | 1995 | 197 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2030 | 0.030 |
Why?
|
Electric Impedance | 1 | 2018 | 741 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 419 | 0.030 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 1994 | 52 | 0.030 |
Why?
|
Nicotine | 1 | 2019 | 676 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1802 | 0.030 |
Why?
|
Triage | 1 | 2021 | 982 | 0.030 |
Why?
|
RNA Splicing | 1 | 2018 | 911 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2017 | 417 | 0.030 |
Why?
|
Triglycerides | 1 | 2021 | 2472 | 0.030 |
Why?
|
Organ Preservation | 1 | 1997 | 364 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1179 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3785 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2015 | 1061 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 4 | 1997 | 1126 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1593 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1746 | 0.030 |
Why?
|
Breast Feeding | 1 | 2021 | 1355 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5608 | 0.030 |
Why?
|
Temperature | 2 | 2016 | 2208 | 0.030 |
Why?
|
Cyclosporins | 1 | 1993 | 215 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1759 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2307 | 0.030 |
Why?
|
Magnetics | 1 | 2016 | 600 | 0.030 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1993 | 97 | 0.030 |
Why?
|
Education | 1 | 2015 | 536 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 382 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1994 | 1142 | 0.030 |
Why?
|
Crithidia | 1 | 1992 | 2 | 0.030 |
Why?
|
Trypanosoma congolense | 1 | 1992 | 2 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1992 | 297 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2012 | 38 | 0.030 |
Why?
|
gamma-Glutamyltransferase | 1 | 2012 | 142 | 0.030 |
Why?
|
Glutathione Reductase | 1 | 1992 | 24 | 0.030 |
Why?
|
Anemia, Aplastic | 1 | 2014 | 228 | 0.030 |
Why?
|
Trypanosomiasis, African | 1 | 1992 | 29 | 0.030 |
Why?
|
Ischemia | 2 | 1997 | 1891 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2416 | 0.020 |
Why?
|
Drug Synergism | 1 | 2016 | 1747 | 0.020 |
Why?
|
India | 1 | 2018 | 2325 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2021 | 2058 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2012 | 400 | 0.020 |
Why?
|
Leishmania tropica | 1 | 1991 | 8 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1992 | 1691 | 0.020 |
Why?
|
Phlebotomus | 1 | 1991 | 12 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2108 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2020 | 14318 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4229 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2476 | 0.020 |
Why?
|
Protein Binding | 2 | 1994 | 9300 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 167 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2012 | 526 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 1986 | 0.020 |
Why?
|
Body Mass Index | 2 | 2021 | 12844 | 0.020 |
Why?
|
Caregivers | 1 | 2023 | 2192 | 0.020 |
Why?
|
Rural Population | 1 | 2021 | 2247 | 0.020 |
Why?
|
Ear, Inner | 1 | 2014 | 423 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 978 | 0.020 |
Why?
|
Alleles | 1 | 2022 | 6886 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3065 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 775 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1896 | 0.020 |
Why?
|
Fruit | 1 | 2015 | 1159 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2104 | 0.020 |
Why?
|
Critical Illness | 1 | 2023 | 2696 | 0.020 |
Why?
|
Spirometry | 1 | 2013 | 914 | 0.020 |
Why?
|
Chagas Disease | 1 | 1992 | 164 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2012 | 605 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1772 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2012 | 777 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3289 | 0.020 |
Why?
|
Genes, Viral | 1 | 1991 | 650 | 0.020 |
Why?
|
Patient Care Team | 1 | 2021 | 2503 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 727 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3480 | 0.020 |
Why?
|
Virus Diseases | 1 | 2015 | 721 | 0.020 |
Why?
|
Heparin | 1 | 2016 | 1653 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6118 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 930 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 3 | 1997 | 1415 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10806 | 0.020 |
Why?
|
Thymus Gland | 1 | 2013 | 1220 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1994 | 3087 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3966 | 0.020 |
Why?
|
Protein Engineering | 1 | 1992 | 541 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1992 | 2754 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2787 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 883 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1629 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3525 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2021 | 3946 | 0.020 |
Why?
|
Substrate Specificity | 1 | 1992 | 1790 | 0.020 |
Why?
|
Endothelins | 2 | 1997 | 124 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1825 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 1332 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3284 | 0.020 |
Why?
|
Simplexvirus | 1 | 1991 | 804 | 0.020 |
Why?
|
Hypertension | 2 | 2020 | 8532 | 0.020 |
Why?
|
Gene Library | 1 | 2009 | 1059 | 0.020 |
Why?
|
Autoimmunity | 1 | 2015 | 1350 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1991 | 1527 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3760 | 0.020 |
Why?
|
Genotype | 2 | 2011 | 12876 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1355 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 1998 | 1881 | 0.020 |
Why?
|
Kidney Glomerulus | 2 | 2000 | 565 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1992 | 2214 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8558 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1602 | 0.020 |
Why?
|
Transforming Growth Factor beta | 3 | 1997 | 1942 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2810 | 0.020 |
Why?
|
Antibodies | 1 | 2013 | 2414 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3772 | 0.020 |
Why?
|
Drosophila | 1 | 1992 | 1493 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9719 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1001 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8159 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7439 | 0.010 |
Why?
|
Cell Line | 2 | 2016 | 15638 | 0.010 |
Why?
|
Lung | 1 | 2023 | 9924 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1991 | 1343 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3561 | 0.010 |
Why?
|
Anxiety | 1 | 2019 | 4481 | 0.010 |
Why?
|
Alanine | 1 | 2006 | 593 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7776 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2011 | 10382 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4111 | 0.010 |
Why?
|
Metabolomics | 1 | 2012 | 1613 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1992 | 6533 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2014 | 2292 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4919 | 0.010 |
Why?
|
Blotting, Southern | 2 | 1994 | 782 | 0.010 |
Why?
|
Nephrectomy | 2 | 1997 | 1011 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7222 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4065 | 0.010 |
Why?
|
Anticoagulants | 1 | 2016 | 4864 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10491 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2000 | 59 | 0.010 |
Why?
|
Ligands | 2 | 1997 | 3288 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2000 | 134 | 0.010 |
Why?
|
Peptide Fragments | 1 | 1992 | 5085 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4284 | 0.010 |
Why?
|
Trazodone | 1 | 1998 | 68 | 0.010 |
Why?
|
Hemodynamics | 2 | 2000 | 4185 | 0.010 |
Why?
|
Complement C1 | 1 | 1997 | 32 | 0.010 |
Why?
|
Raffinose | 1 | 1997 | 52 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6506 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7943 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1997 | 302 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21259 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15669 | 0.010 |
Why?
|
Allopurinol | 1 | 1997 | 200 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 448 | 0.010 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 1998 | 488 | 0.010 |
Why?
|
E-Selectin | 1 | 1997 | 575 | 0.010 |
Why?
|
Isoantigens | 1 | 1996 | 496 | 0.010 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1997 | 325 | 0.010 |
Why?
|
Cold Temperature | 1 | 1997 | 777 | 0.010 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2000 | 1003 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8438 | 0.010 |
Why?
|
Interleukins | 1 | 1997 | 775 | 0.010 |
Why?
|
Cryopreservation | 1 | 1997 | 711 | 0.010 |
Why?
|
Organ Size | 1 | 1997 | 2248 | 0.010 |
Why?
|
Adenosine | 1 | 1997 | 827 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 1994 | 563 | 0.010 |
Why?
|
Bucladesine | 1 | 1991 | 118 | 0.010 |
Why?
|
TATA Box | 1 | 1991 | 127 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1991 | 852 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1997 | 2214 | 0.010 |
Why?
|
Vero Cells | 1 | 1991 | 482 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 818 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1305 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1997 | 2115 | 0.000 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 1991 | 490 | 0.000 |
Why?
|
Oligopeptides | 1 | 1994 | 1186 | 0.000 |
Why?
|
Nerve Growth Factors | 1 | 1991 | 562 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12203 | 0.000 |
Why?
|
Acute Disease | 1 | 1998 | 7229 | 0.000 |
Why?
|
Species Specificity | 1 | 1991 | 2409 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1997 | 2058 | 0.000 |
Why?
|
Body Weight | 1 | 1997 | 4608 | 0.000 |
Why?
|
Gene Amplification | 1 | 1991 | 1081 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1994 | 3725 | 0.000 |
Why?
|
Drug Resistance | 1 | 1991 | 1611 | 0.000 |
Why?
|
Genetic Markers | 1 | 1991 | 2607 | 0.000 |
Why?
|
Insulin | 1 | 1997 | 6571 | 0.000 |
Why?
|